Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide
Clinical trial NCT02991456 · COMPLETED
Trial details
- NCT number
- NCT02991456
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2022-05-09
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.